open access

Vol 6, No 6 (2010)
Guidelines / Expert consensus
Published online: 2011-02-24
Get Citation

Recommendations for diagnostics and therapy of adult patients with malignant primary bone tumors

Piotr Rutkowski, Tomasz Mazurkiewicz, Maciej Krzakowski, Konrad Ptaszyński, Teresa Klepacka, Urszula Grzesiakowska, Sławomir Falkowski, Tomasz Świtaj, Zbigniew Nowecki, Tadeusz Morysiński, Jerzy Spindel, Ewa Chmielik, Szymon Dragan, Jerzy Nazar, Daniel Kotrych, Jan Skowroński, Anna Szumera-Ciećkiewicz, Andrzej Szafrański, Justyna Szumiło, Marta Karpik, Karol Balcerkiewicz, Roman Mazuryk, Bożena Jarosz, Magdalena Rychłowska-Pruszyńska, Marta Rzeszutko, Andrzej Nowakowski
Onkol. Prak. Klin 2010;6(6):355-369.

open access

Vol 6, No 6 (2010)
EXPERTS' OPINION
Published online: 2011-02-24

Abstract

Bone sarcomas comprise a heterogenous group of rare mesenchymal tumors (less than 0.5% of malignant neoplasms in adults). From clinical point of view they can be divided into two main groups: spindle-cell sarcomas (osteosarcomas, majority of chondrosarcomas and less common subtypes) and small-cell sarcomas (mainly Ewing family of tumors). Correct diagnosis and effective therapy is performed by cooperation of radiologists, oncological and orthopedics surgeons, clinical oncologists, radiotherapists, rehabilitants, pathologists, nuclear medicine specialists and molecular biologists. The most important principle in diagnostics and therapy of primary malignant bone tumors is multidisciplinary work in experienced centers. Improvement of diagnostics, implementation of combined therapy and technological developments caused the increase of limb-sparing surgery indications and better long-term results of their treatment.

Onkol. Prak. Klin. 2010; 6, 6: 355–369

Abstract

Bone sarcomas comprise a heterogenous group of rare mesenchymal tumors (less than 0.5% of malignant neoplasms in adults). From clinical point of view they can be divided into two main groups: spindle-cell sarcomas (osteosarcomas, majority of chondrosarcomas and less common subtypes) and small-cell sarcomas (mainly Ewing family of tumors). Correct diagnosis and effective therapy is performed by cooperation of radiologists, oncological and orthopedics surgeons, clinical oncologists, radiotherapists, rehabilitants, pathologists, nuclear medicine specialists and molecular biologists. The most important principle in diagnostics and therapy of primary malignant bone tumors is multidisciplinary work in experienced centers. Improvement of diagnostics, implementation of combined therapy and technological developments caused the increase of limb-sparing surgery indications and better long-term results of their treatment.

Onkol. Prak. Klin. 2010; 6, 6: 355–369

Get Citation

Keywords

bone sarcomas; recommendations; diagnostics; therapy

About this article
Title

Recommendations for diagnostics and therapy of adult patients with malignant primary bone tumors

Journal

Oncology in Clinical Practice

Issue

Vol 6, No 6 (2010)

Article type

Guidelines / Expert consensus

Pages

355-369

Published online

2011-02-24

Bibliographic record

Onkol. Prak. Klin 2010;6(6):355-369.

Keywords

bone sarcomas
recommendations
diagnostics
therapy

Authors

Piotr Rutkowski
Tomasz Mazurkiewicz
Maciej Krzakowski
Konrad Ptaszyński
Teresa Klepacka
Urszula Grzesiakowska
Sławomir Falkowski
Tomasz Świtaj
Zbigniew Nowecki
Tadeusz Morysiński
Jerzy Spindel
Ewa Chmielik
Szymon Dragan
Jerzy Nazar
Daniel Kotrych
Jan Skowroński
Anna Szumera-Ciećkiewicz
Andrzej Szafrański
Justyna Szumiło
Marta Karpik
Karol Balcerkiewicz
Roman Mazuryk
Bożena Jarosz
Magdalena Rychłowska-Pruszyńska
Marta Rzeszutko
Andrzej Nowakowski

References (8)
  1. Bacci G, Picci P, Ruggieri P. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer. 1990; 65: 2539–2553.
  2. Dorfman H, Czerniak B. Bone cancers. Cancer. 1995; 75(S1): 203–210, doi: 10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v.
  3. Grier HE. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am. 1997; 44(4): 991–1004.
  4. Hohendoorn PCW. on behalf of the ESMO/EUROBONET Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010(supl. 5): v204–v213.
  5. Ruka W. Pierwotne nowotwory złośliwe kości u dorosłych. In: Krzakowski M. ed. Onkologia kliniczna. Borgis, Warszawa 2006.
  6. Spanier SS, Shuster JJ, Vander Griend RA. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am. 1990; 72(5): 643–653.
  7. Yasko AW, Johnson ME. Surgical management of primary bone sarcomas. Hematol Oncol Clin North Am. 1995; 9(4): 719–731.
  8. NCCN Clinical Practice Guidelines in Oncology. Bone Cancer Wersja. : Wersja 3.10.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl